Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.36 |
| ▸ | TNNC1 | P63316 | 5/20 | 0.31 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | GPR183 | P32249 | 1/20 | 0.31 |
| ▸ | CERS2 | Q96G23 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9681934 | 0.98 | TSHR (0.44) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| SCHEMBL28615894 | 0.98 | TSHR (0.44) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| SCHEMBL9463177 | 0.98 | TSHR (0.44) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| SCHEMBL11043945 | 0.98 | TSHR (0.44) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| Hydrochloric Acid SCHEMBL11578293 | 0.96 | TSHR (0.43) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| Bromide SCHEMBL29216856 | 0.96 | TSHR (0.43) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| Hydrochloric Acid SCHEMBL11722444 | 0.96 | TSHR (0.43) | TSHRALDH1A1FDPSSMPD1TNNC1 | |
| SCHEMBL9245821 | 0.93 | TSHR (0.40) | TSHRALDH1A1FDPS | |
| Bromide SCHEMBL9850859 | 0.91 | TSHR (0.39) | TSHRALDH1A1FDPS | |
| SCHEMBL9701841 | 0.88 | SMPD1 (0.40) | TSHRALDH1A1FDPSSMPD1TNNC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111213094-B | Charging member for electrophotographic apparatus | 住友理工株式会社 | 2022-04-19 | — | — | CN | disclosed |
| US-10795277-B2 | Charging member for electrophotographic apparatus | SUMITOMO RIKO COMPANY LIMITED (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20200209779-A1 | CHARGING MEMBER FOR ELECTROPHOTOGRAPHIC APPARATUS | SUMITOMO RIKO COMPANY LIMITED (JP) | 2020-07-02 | — | — | US | disclosed |
| CN-111213094-A | Charging member for electrophotographic apparatus | 住友理工株式会社 | 2020-05-29 | — | — | CN | disclosed |
| US-7745654-B2 | Process for the preparation of vinyl- or allyl-containing compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-29 | — | — | US | disclosed |
| EP-1840115-A2 | Process for the preparation of vinyl- or allyl-containing compounds | Daicel Chemical Industries, Ltd. (JP) | 2007-10-03 | — | — | EP | disclosed |
| US-20070213549-A1 | Process for the preparation of vinyl- or allyl-containing compounds | DAICEL CHEMICAL INDUSTRIES, LTD. | 2007-09-13 | — | — | US | disclosed |
| US-5173209-A | Concentrated solvent reagent; high solubility; chemical intermediates for steroids and fragrance | CYPRUS FOOTE MINERAL COMPANY (US) | 1992-12-22 | — | — | US | disclosed |
| US-5149457-A | In monocyclic aromatic solvent; ether-free | CYPRUS FOOTE MINERAL COMPANY (US) | 1992-09-22 | — | — | US | disclosed |
| EP-0406197-A2 | Stable lithium amides and reagent compositions thereof | CYPRUS FOOTE MINERAL COMPANY (US) | 1991-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213549-A1 | Process for the preparation of vinyl- or allyl-containing compounds | ESRRB, NR0B2, ESRRA | TSHR 968/4885ALDH1A1 1891/4885FDPS 2985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.